Whole Genome Sequencing Market Size

Whole Genome Sequencing Market Size

Whole Genome Sequencing (WGS) Market size was valued to be USD 5.5 billion in 2022 and is expected to reach USD 30.1 billion in 2032 with a CAGR of 18.7% from 2023 to 2032. The market is largely driven increasing prevalence of genetic disorders is contributing to the expansion of market.

To get key market trends

  Download Free Sample

For instance, according to the Centers for Disease Control and Prevention statistics, around 1 in every 707 newborn children in the U.S. suffer from down syndrome, which accounts for approximately 5,568 children in the U.S. alone Therefore, whole genome sequencing is widely used for the early detection of genetic diseases. Thus, WGS plays a vital role in identifying the most effective treatment options for individual cancer patients, thereby driving the market’s expansion.

Whole genome sequencing (WGS) is a laboratory procedure that determines the order of bases in the genome of an organism in one process. It is a comprehensive method for analysing entire genomes and is used to obtain detailed information about bacteria, plants, and mammals using just one test. They can detect single nucleotide variants, insertions/deletions, copy number changes, and large structural variants.